We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The compan ...
Recent health news highlights a 10% rise in child TB infections in Europe, detected mammal bird flu cases, and economic ...
Current health news highlights a 10% rise in child TB infections in Europe, a new drug review by European regulators, the ...
6d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of Nucala in COPDGSK plc GSK announced that the European Medicines Agency (“EMA”) has accepted for review a regulatory filing, seeking ...
GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal ...
GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of ‘Nucala’, or ...
London open The FTSE 100 is expected to open 28 points higher on Monday, having closed down 0.63% on Friday at 8,646.79.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results